| Primary |
| Epilepsy |
27.2% |
| Drug Exposure During Pregnancy |
22.5% |
| Drug Use For Unknown Indication |
15.3% |
| Product Used For Unknown Indication |
8.7% |
| Migraine Prophylaxis |
5.2% |
| Migraine |
4.0% |
| Partial Seizures |
2.9% |
| Foetal Exposure During Pregnancy |
1.7% |
| Headache |
1.7% |
| Drug Dependence |
1.4% |
| Abnormal Behaviour |
1.2% |
| Bipolar I Disorder |
1.2% |
| Bronchitis Acute |
0.9% |
| Contraception |
0.9% |
| Convulsion Prophylaxis |
0.9% |
| Drug Rehabilitation |
0.9% |
| Drug Toxicity |
0.9% |
| Encephalopathy |
0.9% |
| Post-traumatic Epilepsy |
0.9% |
| Tremor |
0.9% |
|
| Drug Exposure During Pregnancy |
14.5% |
| Weight Decreased |
14.5% |
| Premature Baby |
10.8% |
| Off Label Use |
7.2% |
| Retrognathia |
4.8% |
| Ventricular Septal Defect |
4.8% |
| Visual Acuity Reduced |
4.8% |
| Cataract |
3.6% |
| Drug Interaction |
3.6% |
| Pulmonary Arterial Hypertension |
3.6% |
| Status Epilepticus |
3.6% |
| Visual Field Defect |
3.6% |
| Vomiting |
3.6% |
| Dyspnoea |
2.4% |
| Epilepsy |
2.4% |
| Feeling Drunk |
2.4% |
| Growth Retardation |
2.4% |
| Heart Disease Congenital |
2.4% |
| Neutropenia |
2.4% |
| Paraesthesia |
2.4% |
|
| Secondary |
| Epilepsy |
43.0% |
| Drug Use For Unknown Indication |
15.1% |
| Product Used For Unknown Indication |
10.7% |
| Migraine Prophylaxis |
4.8% |
| Abnormal Behaviour |
4.5% |
| Migraine |
3.1% |
| Partial Seizures |
2.7% |
| Bipolar Disorder |
2.1% |
| Drug Dependence |
2.1% |
| Encephalopathy |
2.1% |
| Convulsion Prophylaxis |
1.7% |
| Bipolar I Disorder |
1.4% |
| Pyrexia |
1.4% |
| Drug Toxicity |
1.0% |
| Tremor |
1.0% |
| Anaesthesia |
0.7% |
| Antidepressant Therapy |
0.7% |
| Contraception |
0.7% |
| Hypersensitivity |
0.7% |
| Intra-uterine Contraceptive Device |
0.7% |
|
| Off Label Use |
17.6% |
| Weight Decreased |
10.6% |
| Suicidal Ideation |
8.2% |
| Premature Baby |
7.1% |
| Drug Exposure During Pregnancy |
4.7% |
| Hepatitis |
4.7% |
| Paraesthesia |
4.7% |
| Pyrexia |
4.7% |
| Renal Failure Acute |
4.7% |
| Foetal Death |
3.5% |
| Intra-uterine Death |
3.5% |
| Panic Reaction |
3.5% |
| Syndactyly |
3.5% |
| Tonic Convulsion |
3.5% |
| Vomiting |
3.5% |
| Carpal Tunnel Syndrome |
2.4% |
| Feeling Drunk |
2.4% |
| Foetal Exposure During Pregnancy |
2.4% |
| Growth Retardation |
2.4% |
| Insomnia |
2.4% |
|
| Concomitant |
| Epilepsy |
36.4% |
| Product Used For Unknown Indication |
16.0% |
| Drug Use For Unknown Indication |
8.2% |
| Partial Seizures |
6.1% |
| Migraine |
4.3% |
| Pain |
3.5% |
| Abdominal Pain |
2.6% |
| Convulsion |
2.6% |
| Depression |
2.6% |
| Encephalitis |
2.6% |
| Oligodendroglioma |
2.6% |
| Multiple Sclerosis |
2.2% |
| Deep Vein Thrombosis |
1.7% |
| Respiratory Failure |
1.7% |
| Atrial Fibrillation |
1.3% |
| Bipolar Disorder |
1.3% |
| Headache |
1.3% |
| Induction Of Anaesthesia |
1.3% |
| Abnormal Behaviour |
0.9% |
| Affective Disorder |
0.9% |
|
| Somnolence |
17.0% |
| Thrombocytopenia |
17.0% |
| Vomiting |
9.4% |
| Weight Decreased |
7.5% |
| Epilepsy |
5.7% |
| Pharmaceutical Product Complaint |
5.7% |
| Pseudomonas Infection |
3.8% |
| Rash |
3.8% |
| Shoulder Deformity |
3.8% |
| Status Epilepticus |
3.8% |
| Urticaria |
3.8% |
| Weight Increased |
3.8% |
| Anaphylactic Shock |
1.9% |
| Deafness Bilateral |
1.9% |
| Deep Vein Thrombosis |
1.9% |
| Dermatitis Exfoliative |
1.9% |
| Dermo-hypodermitis |
1.9% |
| Disease Progression |
1.9% |
| Drug Abuser |
1.9% |
| Gastrointestinal Disorder |
1.9% |
|
